DCF — BROWARD HEALTH CORAL SPRINGS
Enterprise Value: $-182.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-182.0M
Enterprise Value
$-61.3M
PV of Cash Flows
$-120.7M
PV of Terminal Value
$-194.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $223.7M | $-9.3M | -4.0% | $-18.8M | $-17.1M |
| Year 2 | $230.5M | $-7.3M | -3.0% | $-17.1M | $-14.1M |
| Year 3 | $237.4M | $-5.1M | -2.0% | $-15.2M | $-11.4M |
| Year 4 | $244.5M | $-4.1M | -2.0% | $-14.4M | $-9.9M |
| Year 5 | $251.8M | $-3.6M | -1.0% | $-14.2M | $-8.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-182.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$217.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0466640984117285
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5